Hengrui weighs Hong Kong IPO to drive the next phase of global expansion
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge. The post Hengrui weighs Hong Kong IPO to drive the next phase of global expansion appeared first on KrASIA…
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.
The post Hengrui weighs Hong Kong IPO to drive the next phase of global expansion appeared first on KrASIA…
Read More
About Author
